Valérie Pilorget, MD
Sanofi
8
0
6
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Lisa Porter, MD
Amylin Pharmaceuticals, LLC.
Shared therapeutic areas:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
Timothy Bailey, MD
AMCR Institute
Shared therapeutic areas:
Adrian Vella, MD
Mayo Clinic
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
Insulin Glulisine in Diabetes Mellitus, Type 2
Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes
VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt
Insulin Glulisine in Type 2 Diabetes Mellitus
Insulin Glulisine in Healthy Lean and Obese Subjects
Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose
European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia
All 8 trials loaded